Pediatric emergency care · 2025
Using a Clinical Pathway to Safely Reduce Transfers and Admissions for Croup in the Urgent Care.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wyly Donna R, Berg Kathleen, Melanson Andrea, Gripka Megan, Skoglund David, Blanco Maria V, Nedved Amanda
Аннотация
OBJECTIVE: To evaluate the impact of a croup clinical pathway (CP) on transfer rates from our urgent cares (UCs).
METHODS: We revised our croup CP in November 2022 to recommend giving additional doses of racemic epinephrine (RE) in UC before transferring a patient and using shared decision-making with families on post-RE observation of their child at home or in a clinical setting. We conducted a retrospective cohort study of patients with croup in 3 UCs who received RE in the pre-CP revision (November 2021 to October 2022) and post-CP revision (November 2022 to October 2023) periods. Interrupted time series analysis evaluated trends over time.
RESULTS: We reviewed encounters of 1575 patients diagnosed with croup in the pre-CP revision and 1530 patients in the post-CP revision. In the pre-CP revision period, 77 patients (4.9%) received RE, and 94 patients (6.1%) received RE in the post-CP revision ( P =0.09). We saw a decrease in patients who received RE that were transferred from 32.5% in the pre-CP revision period (32.5%) to 10.6% in the post-CP revision period (odds ratio, 0.25; 95% CI, 0.11-0.56; P <0.001). However, Interrupted time series analysis demonstrated downward trends in both time periods with no significant difference over time. Patients discharged within 90 minutes of the last RE increased from 13.5% pre-CP revision to 33.3% post-CP revision (odds ratio, 3.83; 95% CI, 1.46-10.05; P =0.008). We did not see a change in return visits at 24 or 72 hours.
CONCLUSION: Although we saw a downward trend in the percentage of patients with croup transferred after receiving RE in our UCs post-CP revision, we did not see a significant decrease over time. However, this study demonstrates that providing additional RE doses for croup in UC and using shared decision-making with families in the setting for observation did not increase length of stay or return visits.
METHODS: We revised our croup CP in November 2022 to recommend giving additional doses of racemic epinephrine (RE) in UC before transferring a patient and using shared decision-making with families on post-RE observation of their child at home or in a clinical setting. We conducted a retrospective cohort study of patients with croup in 3 UCs who received RE in the pre-CP revision (November 2021 to October 2022) and post-CP revision (November 2022 to October 2023) periods. Interrupted time series analysis evaluated trends over time.
RESULTS: We reviewed encounters of 1575 patients diagnosed with croup in the pre-CP revision and 1530 patients in the post-CP revision. In the pre-CP revision period, 77 patients (4.9%) received RE, and 94 patients (6.1%) received RE in the post-CP revision ( P =0.09). We saw a decrease in patients who received RE that were transferred from 32.5% in the pre-CP revision period (32.5%) to 10.6% in the post-CP revision period (odds ratio, 0.25; 95% CI, 0.11-0.56; P <0.001). However, Interrupted time series analysis demonstrated downward trends in both time periods with no significant difference over time. Patients discharged within 90 minutes of the last RE increased from 13.5% pre-CP revision to 33.3% post-CP revision (odds ratio, 3.83; 95% CI, 1.46-10.05; P =0.008). We did not see a change in return visits at 24 or 72 hours.
CONCLUSION: Although we saw a downward trend in the percentage of patients with croup transferred after receiving RE in our UCs post-CP revision, we did not see a significant decrease over time. However, this study demonstrates that providing additional RE doses for croup in UC and using shared decision-making with families in the setting for observation did not increase length of stay or return visits.